FDA — authorised 18 March 2016
- Marketing authorisation holder: ELUSYS THERAPEUTICS INC
- Status: approved
🇺🇸 Anthim in United States
FDA authorised Anthim on 18 March 2016
Marketing authorisations
FDA — authorised 18 March 2016
- Application: BLA125509
- Marketing authorisation holder: ELUSYS THERAPEUTICS INC
- Local brand name: ANTHIM
- Indication: INJECTABLE — INJECTION
- Status: approved
Anthim in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Anthim approved in United States?
Yes. FDA authorised it on 18 March 2016; FDA authorised it on 18 March 2016.
Who is the marketing authorisation holder for Anthim in United States?
ELUSYS THERAPEUTICS INC holds the US marketing authorisation.